Simon Beaudoin Department of Nuclear Medicine and Radiobiology Université de Sherbrooke Biography Publications Institution JoVE Articles Simon Beaudoin has not added a biography. If you are Simon Beaudoin and would like to personalize this page please email our Author Liaison for assistance. Publications Targeting IL-5Rα with Antibody-conjugates Reveals a Strategy for Imaging and Therapy for Invasive Bladder Cancer Oncoimmunology. 2017 | Pubmed ID: 29123949 BODIPY-17α-ethynylestradiol Conjugates: Synthesis, Fluorescence Properties and Receptor Binding Affinities Bioorganic & Medicinal Chemistry Letters. Feb, 2017 | Pubmed ID: 28049591 Development of a Novel Covalent Folate-Albumin-Photosensitizer Conjugate Photochemistry and Photobiology. 07, 2016 | Pubmed ID: 27221219 ChAcNLS, a Novel Modification to Antibody-Conjugates Permitting Target Cell-Specific Endosomal Escape, Localization to the Nucleus, and Enhanced Total Intracellular Accumulation Molecular Pharmaceutics. Jun, 2016 | Pubmed ID: 27112376 Aggregation and Neurotoxicity of Recombinant α-synuclein Aggregates Initiated by Dimerization Molecular Neurodegeneration. Jan, 2013 | Pubmed ID: 23339399 A Large Ribonucleoprotein Particle Induced by Cytoplasmic PrP Shares Striking Similarities with the Chromatoid Body, an RNA Granule Predicted to Function in Posttranscriptional Gene Regulation Biochimica Et Biophysica Acta. Feb, 2009 | Pubmed ID: 19014979 Aggresomes Do Not Represent a General Cellular Response to Protein Misfolding in Mammalian Cells BMC Cell Biology. Oct, 2008 | Pubmed ID: 18937858 Prion Protein Aggresomes Are Poly(A)+ Ribonucleoprotein Complexes That Induce a PKR-mediated Deficient Cell Stress Response Biochimica Et Biophysica Acta. Mar, 2008 | Pubmed ID: 18023289 Evaluación inicial de los conjugados de anticuerpos modificados con péptidos virales derivados para aumentar la acumulación celular y mejorar Tumor Targeting Simon Beaudoin1, Michel Paquette1, Laurent Fafard-Couture1, Mylene A. Tremblay1, Roger Lecomte1,2,3, Brigitte Guérin1,2,3, Jeffrey V. Leyton1,2,3 1Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, 2Sherbrooke Molecular Imaging Center (CIMS), Université de Sherbrooke, 3Sherbrooke Institute of Pharmacology JoVE 55440 Bioengineering
Evaluación inicial de los conjugados de anticuerpos modificados con péptidos virales derivados para aumentar la acumulación celular y mejorar Tumor Targeting Simon Beaudoin1, Michel Paquette1, Laurent Fafard-Couture1, Mylene A. Tremblay1, Roger Lecomte1,2,3, Brigitte Guérin1,2,3, Jeffrey V. Leyton1,2,3 1Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, 2Sherbrooke Molecular Imaging Center (CIMS), Université de Sherbrooke, 3Sherbrooke Institute of Pharmacology JoVE 55440 Bioengineering
